Stock Research for HTGZ

HTGZ

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

HTGZ Stock Chart & Research Data

The HTGZ chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the HTGZ chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


HTGZ Due diligence Resources & Stock Charts

The HTGZ stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View HTGZ Detailed Price Forecast - CNN Money CNN View HTGZ Detailed Summary - Google Finance
Yahoo View HTGZ Detailed Summary - Yahoo! Finance Zacks View HTGZ Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View HTGZ Trends & Analysis - Trade-Ideas Barrons View HTGZ Major Holders - Barrons
NASDAQ View HTGZ Call Transcripts - NASDAQ Seeking View HTGZ Breaking News & Analysis - Seeking Alpha
Spotlight View HTGZ Annual Report - CompanySpotlight.com OTC Report View HTGZ OTC Short Report - OTCShortReport.com
TradeKing View HTGZ Fundamentals - TradeKing Charts View HTGZ SEC Filings - Bar Chart
WSJ View Historical Prices for HTGZ - The WSJ Morningstar View Performance/Total Return for HTGZ - Morningstar
MarketWatch View the Analyst Estimates for HTGZ - MarketWatch CNBC View the Earnings History for HTGZ - CNBC
StockMarketWatch View the HTGZ Earnings - StockMarketWatch MacroAxis View HTGZ Buy or Sell Recommendations - MacroAxis
Bullish View the HTGZ Bullish Patterns - American Bulls Short Pains View HTGZ Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View HTGZ Stock Mentions - StockTwits PennyStocks View HTGZ Stock Mentions - PennyStockTweets
Twitter View HTGZ Stock Mentions - Twitter Invest Hub View HTGZ Investment Forum News - Investor Hub
Yahoo View HTGZ Stock Mentions - Yahoo! Message Board Seeking Alpha View HTGZ Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for HTGZ - SECform4.com Insider Cow View Insider Transactions for HTGZ - Insider Cow
CNBC View HTGZ Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for HTGZ - OTC Markets
Yahoo View Insider Transactions for HTGZ - Yahoo! Finance NASDAQ View Institutional Holdings for HTGZ - NASDAQ


Stock Charts

FinViz View HTGZ Stock Insight & Charts - FinViz.com StockCharts View HTGZ Investment Charts - StockCharts.com
BarChart View HTGZ Stock Overview & Charts - BarChart Trading View View HTGZ User Generated Charts - Trading View




Latest Financial News for HTGZ


Hercules Tech: 2Q Earnings Snapshot
Posted on Thursday August 02, 2018

On a per-share basis, the Palo Alto, California-based company said it had profit of 59 cents. Earnings, adjusted for investment gains, were 29 cents per share. The results surpassed Wall Street expectations. ...


Acacia Pharma Provides Operating Update for the First Half 2018
Posted on Sunday July 08, 2018

 Cambridge, UK and Indianapolis, US - 9 July 2018: Acacia Pharma Group plc ("Acacia Pharma", the "Company" or the "Group"), (ACPH.BR) provides an unaudited operating update for the first half 2018 (six months ended 30 June 2018). Acacia Pharma is a hospital pharmaceutical company focused on the development and commercialisation of new nausea & vomiting treatments for surgical and cancer patients targeting a specific unmet need to improve patient outcomes and lower hospital costs. Dr Julian Gilbert, CEO of Acacia Pharma, commented: "The Group has made important progress during the first half 2018 preparing for the launch, if approved, of BARHEMSYS(TM) for the treatment and prevention of post-operative nausea & vomiting (PONV) in surgical patients.


May Top Value-Adding Stocks
Posted on Thursday May 31, 2018

Are you an investor looking for high-growth, steady income, or both? What makes a suitable investment stock for your personal needs? Given that there are many factors to consider, I’veRead More...


Hercules Tech meets 4Q profit forecasts
Posted on Thursday February 22, 2018

On a per-share basis, the Palo Alto, California-based company said it had net income of 22 cents. Earnings, adjusted for investment costs, came to 29 cents per share. The results met Wall Street expectations. ...


Stock Market & Investing Books

Enter a stock symbol to view the stock details.